In the US, a rare disease or disorder is defined as one that affects fewer than 200,000 people. This means hemophilia A and B, and the less-common factor deficiencies such as I, II, V, VII, X, XI, XII and XIII, are all rare disorders.The National…
Representation of Gender in Research and Clinical Contexts
Speaker(s): Alexis Dinno, MPH; Michael Recht, MD
Did you miss the July 7th Wednesday Webinar? If so click here to listen to Alexis Dinno, MPH; Michael Recht, MD…
COVID Vaccines
Speaker(s): Karen Remley, MD, MBA, MPH
Did you miss the July 14th Wednesday Webinar? If so, click here to listen to Karen Remley, MD, MBA, MPH discuss COVID vaccine implementation.
Register for…
Artificial Intelligence/Machine Learning Research in Hemophilia
Speaker(s): Moses Miles; Michael Recht, MD, Crystal Watson
Did you miss the July 21st Wednesday Webinar series? If so click here to listen to Moses Miles and…
Ensuring Health Equity with Emerging Therapies
Speaker(s): Leonard Valentino, MD
Did you miss the July 28th Wednesday Webinar? If so click here to listen to NHF President and CEO Dr. Len Valentino discuss ensuring health…
State of the Science Update and What to Expect- Part 1 (WGs 1, 3, 4)
Speaker(s): Working Group Members
Did you miss the August 4th Wednesday Webinar? If so click here to listen to Dr. Margaret Ragni, Dr. Maureen Baldwin, and…
State of the Science Update and What to Expect - Part 2 (WGs 2, 4 6)
Speaker(s): Working Group Members
Did you miss the August 11th Wednesday Webinar? If so click here to listen to the State of the Science working group members…
Anti-TFPI for the Treatment of People with Hemophilia
Speaker(s): Michael Wang, MD; Beth Warren, MD
Did you miss the September 8th Wednesday Webinar? If so click here to listen to Dr Beth Warren and Dr Michael Wang from the…
Is Pharmacokinetic Assessment a Step Towards Precision Medicine?
Speaker(s): Leonard Valentino, MD
Did you miss the September 22nd Wednesday Webinar? If so click here to join our President and CEO Dr. Len Valentino discuss the…